Aurealis Therapeutics
Aurealis Therapeutics is a swiss-finnish private biopharmaceutical company Aurealis Therapeutics raised US$9.1M in Venture - Series Unknown funding.
Email and contact information
Company website: aurealistherapeutics.com/
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: Kuopio, (Finland)
Industry: Biotechnology
Business model: B2B
Funding
- Total funding amount: $9,064,837 (in USD)
- Estimated valuation: $45,324,185.00
- Latest deal type: Venture - Series Unknown
- First fundind year: 2024
Growth
Founders:
Top investors:
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK